Sebastian Felix Nepomuk Bode

17PUBLICATIONS
72CO-AUTHORS
Infant and child healthCounselling, wellbeing and community servicesSensor technology (incl. chemical aspects)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - inorganic elements and compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 25, 2026
Impact of Highly Effective CFTR Modulator Therapy on Physical Activity, Sleep, and Sinonasal Symptoms in Preschool Children with Cystic Fibrosis: A Prospective Single-Center Pilot Study.

|Dec 27, 2024
Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI).

Tomke Sütering, Sebastian F N Bode, Rainald Fischer

|Dec 03, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.

Maximilian Stich, Vladimir Gonçalves Magalhães, Friederike Bürger

|Nov 26, 2024
Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study.

Dimitrii Pogorelov, Sebastian Felix Nepomuk Bode, Xin He

|Jun 26, 2024
Biallelic Variants in MNS1 Are Associated with Laterality Defects and Respiratory Involvement.

Rim Hjeij, Joseph Leslie, Hoda Rizk

|Feb 04, 2023
Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis.

Sebastian F N Bode, Hannes Rapp, Nadine Lienert

Pageof 3

Frequent Collaborators

3 joint publications

Dorit Fabricius

3 joint publications

Hanna Renk

3 joint publications

Roland Elling

3 joint publications

Maximillian Stich